Stay updated on Bardoxolone Methyl in Rare Kidney Diseases Clinical Trial
Sign up to get notified when there's something new on the Bardoxolone Methyl in Rare Kidney Diseases Clinical Trial page.

Latest updates to the Bardoxolone Methyl in Rare Kidney Diseases Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedRevision updated from v3.2.0 to v3.3.2 appears as a minor site version note in the page footer and does not affect study content or user actions. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check28 days agoChange DetectedRemoved the government funding status notice that previously appeared on the page. This maintenance change does not alter the study information, such as eligibility criteria, endpoints, or enrollment details. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check42 days agoChange DetectedOnly minor layout adjustments are visible; core study content and key sections such as the overview and eligibility criteria remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check71 days agoChange DetectedUpdated page version to v3.2.0 and added a government operating-status notice; removed the term 'IgA glomerulonephritis' from the content.SummaryDifference3%

- Check78 days agoChange DetectedThe page now shows Revision: v3.1.0, replacing the previous Revision: v3.0.2.SummaryDifference0.1%

- Check92 days agoChange DetectedUpdated from v3.0.1 to v3.0.2. The Back to Top link was removed; no substantive core-content changes are indicated.SummaryDifference0.2%

Stay in the know with updates to Bardoxolone Methyl in Rare Kidney Diseases Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Bardoxolone Methyl in Rare Kidney Diseases Clinical Trial page.